Mapping complex cognitive problems across psychiatric and neurological conditions
Official title: Characterization of High-level Cognitive Impairments in Patients With Neuropsychiatric Disorders
Run by Centre Hospitalier St Anne · NCT07295652 · Data updated 2026-11-12
This project will test a set of cognitive tests and optional brain recordings in adults with psychiatric or neurological disorders and healthy volunteers to map high-level thinking problems and how they change over time.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Centre Hospitalier St Anne Academic / other |
| Locations | 3 sites (Paris and 2 other locations) |
| Status | Recruiting |
| Started | March 12, 2024 |
| Main results expected | March 2039 |
| Study ends | March 2039 |
| Registry record updated | December 19, 2025 |
| Trial ID | NCT07295652 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with a diagnosed psychiatric disorder (e.g., schizophrenia, bipolar, depressive, ASD, OCD) or a diagnosed neurological disorder (e.g., neurodegenerative disease, focal lesion, epilepsy) who can give informed consent and attend in-person visits are ideal candidates.
✕Probably not a fit
People unable to complete cognitive testing due to severe motor or sensory impairment, those with active substance use disorder (except tobacco), or with unstable acute medical or psychiatric conditions are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project will build a multidimensional, transdiagnostic atlas of high-level cognitive impairments by testing adults with a range of psychiatric and neurological diagnoses alongside healthy volunteers. Cognitive testing will be combined with optional MRI, EEG, and MEG to link behavioral profiles with brain measures. Tests will be iteratively refined to be shorter, more ergonomic, and suitable for digital platforms based on participant feedback and interim analyses. Repeated evaluations are planned to track changes with clinical course and routine treatments.
Why it matters
Potential benefit: If successful, the work could produce shorter, more usable digital tests and brain markers that help clinicians track cognitive problems and tailor care.
How similar studies have gone: Previous studies have characterized domain-specific cognitive deficits and linked them to brain measures, but a large transdiagnostic, high-level cognitive atlas combined with adaptive digital tests and multimodal neuroimaging remains relatively novel and not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For patients: * Aged over 18 years * Diagnosed with a psychiatric disorder according to ICD-10 by a psychiatrist (F10-F98) or diagnosed with a neurological disorder according to ICD-10 by a neurologist (G00-G99) * Provided written informed consent * Affiliated with a social security scheme For healthy volunteers: * Aged over 18 years * Provided written informed consent * Affiliated with a social security scheme Exclusion Criteria: For healthy volunteers: * Current diagnosis of a psychiatric disorder according to ICD-10 (F20-F98) or current prescription of a psychotropic medication, or diagnosis of a neurological disorder according to ICD-10 (G00-G99) * History of depression (F32) * Substance use disorder (excluding tobacco) * Neurological history (e.g., stroke, coma, epilepsy, neuroinflammatory or neurodegenerative disease) or identified cognitive disorder * Inability to complete cognitive testing (e.g., due to motor or sensory impairment) For participants undergoing MRI (without contrast agent): * Presence of MRI contraindications: non-MRI-compatible pacemaker, heart valve, implant, or metallic foreign body * Pregnancy at the time of MRI
Where it's running
-
Departement of Adult Psychiatry, GH Pitié Salpétrière
Paris, France Recruiting -
Groupe hospitalo-universitaire Paris Psychiatrie et Neurosciences
Paris, France Recruiting -
Hôpital Fondation Adolphe de Rothschild
Paris, France Not yet recruiting
Study contacts
- Principal investigator: Pierre BOURDILLON, Dr — Hôpital Fondation Adolphe de Rothschild
- Study coordinator: Jacob DHOTE, Dr
- Email: j.dhote@ghu-paris.fr
- Phone: +33 145658177
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
-
Using Lumateperone to improve motivation in patients with schizophrenia and psychosis
This study is testing if Lumateperone can help people with schizophrenia or schizoaffective disorders feel more motivated and less apathetic.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
XEP527 in stable schizophrenia: safety and how it behaves in the body
This small, early-stage study tests the safety and how XEP527 behaves in people with stable schizophrenia who are on a single antipsychotic.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.